| Application no. and date | 19722333.2 (espacenet) (Federated) (European Patent Register), 20190415 | | Patent/reg. no. and date | DK/EP 3781132, 20240320 | | Publication date | 20210224 | | Priority no. and date | US 201862658175 P, 20180416 | | EP pub. no. and date |
EP 3781132 20210224 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 & Province Line Road
Princeton, NJ 08543, US,
Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | PU280834DKQ | | Inventor | BADAWY, Sherif, Ibrahim, Farag, c/o Bristol-Myers Squibb Company
Route 206&Province Line Road
Princeton, NJ 08543-4000, US,
STEVENS, Timothy, D., c/o Bristol-Myers Squibb Company Route 206 &
Province Line Road
Princeton, NJ 08543-4000, US,
KUNTZ, Daniel, c/o Bristol-Myers Squibb Company Route 206 &
Province Line Road
Princeton, NJ 08543-4000, US,
WAYBRANT, Brett, c/o Bristol-Myers Squibb Company Route 206 &
Province Line Road
Princeton, NJ 08543-4000, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 9/16 (2006.01) , A61P 7/02 (2006.01) | | Title | APIXABANFORMULERINGER | | Int. application no. | US2019027456 | | Int. publication no. | WO2019204193 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
